Arch Virol

1. DAHER-NASHIF S, Al-Anany R, Ali M, Erradi K, et al
   COVID-19 exit strategy during vaccine implementation: a balance between social distancing and herd immunity.
   Arch Virol. 2022 Jun 20. pii: 10.1007/s00705-022-05495.
   

   >> Share

   
   

   
   Biochem Biophys Res Commun

2. LYKHMUS O, Kalashnyk O, Koval L, Krynina O, et al
   Immunization with 674-685 fragment of SARS-Cov-2 spike protein induces neuroinflammation and impairs episodic memory of mice.
   Biochem Biophys Res Commun. 2022;622:57-63.
   

   >> Share

   
   

   
   BMJ

3. BADELL ML, Dude CM, Rasmussen SA, Jamieson DJ, et al
   Covid-19 vaccination in pregnancy.
   BMJ. 2022;378:e069741.
   

   >> Share

   
   
4. BOSCOLO-RIZZO P, Polesel J, Vaira LA
   Smell and taste dysfunction after covid-19.
   BMJ. 2022;378:o1653.
   

   >> Share

   
   
5. MAHASE E
   Covid-19: What we know about the BA.4 and BA.5 omicron variants.
   BMJ. 2022;378:o1969.
   

   >> Share

   
   
6. ELLIS SJ
   Covid-19 impact on patients: ease of access should be a clear aim of the NHS.
   BMJ. 2022;378:o1941.
   

   >> Share

   
   
7. MAHASE E
   Covid-19: One in eight adults develops long covid symptoms, study suggests.
   BMJ. 2022;378:o1946.
   

   >> Share

   
   

   
   Cell

8. LI L, Liao H, Meng Y, Li W, et al
   Structural basis of human ACE2 higher binding affinity to currently circulating Omicron SARS-CoV-2 sub-variants BA.2 and BA.1.1.
   Cell. 2022;185:2952-2960.
   

   >> Share

   
   
9. DOLTON G, Rius C, Hasan MS, Wall A, et al
   Emergence of immune escape at dominant SARS-CoV-2 killer T cell epitope.
   Cell. 2022;185:2936-2951.
   

   >> Share

   
   

   
   Drug Saf

10. KANT A, van Hunsel F
    Authors' Reply to Mungmunpuntipantip et al.'s Comment on "Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands".
    Drug Saf. 2022;45:925-926.
    

    >> Share

    
    
11. MUNGMUNPUNTIPANTIP R, Wiwanitkit V
    Comment on "Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands".
    Drug Saf. 2022;45:923.
    

    >> Share

    
    

    
    J Epidemiol Community Health

12. ZELNER J, Naraharisetti R
    Declining COVID-19 mortality risk ratios must be interpreted with caution.
    J Epidemiol Community Health. 2022;76:840.
    

    >> Share

    
    

    
    J Exp Med

13. HALE M, Netland J, Chen Y, Thouvenel CD, et al
    IgM antibodies derived from memory B cells are potent cross-variant neutralizers of SARS-CoV-2.
    J Exp Med. 2022;219.
    

    >> Share

    
    

    
    J Immunol

14. DAI M, Sun H, Zhao L, Wu Q, et al
    Duck CD8(+) T Cell Response to H5N1 Highly Pathogenic Avian Influenza Virus Infection In Vivo and In Vitro.
    J Immunol. 2022 Aug 8. pii: jimmunol.2101147. doi: 10.4049/jimmunol.2101147.
    

    >> Share

    
    

    
    J Infect Dis

15. MAO Z, Li X, Korsten K, Bont L, et al
    Economic Burden and Health-Related Quality of Life of Respiratory Syncytial Virus and Influenza Infection in European Community-Dwelling Older Adults.
    J Infect Dis. 2022;226.
    

    >> Share

    
    

    
    J Virol

16. GUO H, Li A, Lin HF, Liu MQ, et al
    The Glycan-Binding Trait of the Sarbecovirus Spike N-Terminal Domain Reveals an Evolutionary Footprint.
    J Virol. 2022 Jul 19:e0095822. doi: 10.1128/jvi.00958.
    

    >> Share

    
    
17. PUSNIK J, Konig J, Mai K, Richter E, et al
    Persistent Maintenance of Intermediate Memory B Cells Following SARS-CoV-2 Infection and Vaccination Recall Response.
    J Virol. 2022 Jul 12:e0076022. doi: 10.1128/jvi.00760.
    

    >> Share

    
    
18. FARRUKEE R, Gunalan V, Maurer-Stroh S, Reading PC, et al
    Predicting Permissive Mutations That Improve the Fitness of A(H1N1)pdm09 Viruses Bearing the H275Y Neuraminidase Substitution.
    J Virol. 2022;96:e0091822.
    

    >> Share

    
    
19. MOYO-GWETE T, Madzivhandila M, Mkhize NN, Kgagudi P, et al
    Shared N417-Dependent Epitope on the SARS-CoV-2 Omicron, Beta, and Delta Plus Variants.
    J Virol. 2022 Jul 13:e0055822. doi: 10.1128/jvi.00558.
    

    >> Share

    
    
20. FROLOVA EI, Palchevska O, Lukash T, Dominguez F, et al
    Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling.
    J Virol. 2022 Jul 25:e0075322. doi: 10.1128/jvi.00753.
    

    >> Share

    
    

    
    JAMA

21. LARKIN HD
    New "Universal" Flu Vaccine Candidate Enters Clinical Trial.
    JAMA. 2022;328:518.
    

    >> Share

    
    
22. KUEHN BM
    More Effective Flu Vaccines Recommended for Older Adults.
    JAMA. 2022;328:519.
    

    >> Share

    
    
23. KUEHN BM
    Reduced HIV Testing and Diagnoses During COVID-19 Pandemic.
    JAMA. 2022;328:519.
    

    >> Share

    
    
24. CARDOSO CC, Rossi AD, Galliez RM, Faffe DS, et al
    Olfactory Dysfunction in Patients With Mild COVID-19 During Gamma, Delta, and Omicron Waves in Rio de Janeiro, Brazil.
    JAMA. 2022 Jun 24. pii: 2793811. doi: 10.1001/jama.2022.11006.
    

    >> Share

    
    

    
    Lancet

25. BRIGHTLING CE, Evans RA
    Long COVID: which symptoms can be attributed to SARS-CoV-2 infection?
    Lancet. 2022;400:411-413.
    

    >> Share

    
    
26. VAN DAMME W, Wamai R, Assefa Y, Liesenborghs L, et al
    COVID-19 and microbiome diversity in sub-Saharan Africa.
    Lancet. 2022;400:429.
    

    >> Share

    
    
27. SORENSEN RJD
    COVID-19 and microbiome diversity in sub-Saharan Africa - Author's reply.
    Lancet. 2022;400:429-430.
    

    >> Share

    
    
28. BALLERING AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM, et al
    Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study.
    Lancet. 2022;400:452-461.
    

    >> Share

    
    

    
    MMWR Morb Mortal Wkly Rep

29. KHUON D, Ogrin S, Engels J, Aldrich A, et al
    Notes from the Field: Increase in Pediatric Intracranial Infections During the COVID-19 Pandemic - Eight Pediatric Hospitals, United States, March 2020-March 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1000-1001.
    

    >> Share

    
    
30. TWENTYMAN E, Wallace M, Roper LE, Anderson TC, et al
    Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged >/=18 years - United States, July 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:988-992.
    

    >> Share

    
    
31. KOMPANIYETS L, Bull-Otterson L, Boehmer TK, Baca S, et al
    Post-COVID-19 Symptoms and Conditions Among Children and Adolescents - United States, March 1, 2020-January 31, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:993-999.
    

    >> Share

    
    

    
    N Engl J Med

32. LAUNAY O, Cachanado M, Luong Nguyen LB, Ninove L, et al
    Immunogenicity and Safety of Beta-Adjuvanted Recombinant Booster Vaccine.
    N Engl J Med. 2022 Jun 29. doi: 10.1056/NEJMc2206711.
    

    >> Share

    
    
33. TAKASHITA E, Yamayoshi S, Simon V, van Bakel H, et al
    Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants.
    N Engl J Med. 2022;387:468-470.
    

    >> Share

    
    
34. MAIER HE, Balmaseda A, Saborio S, Ojeda S, et al
    Protection Associated with Previous SARS-CoV-2 Infection in Nicaragua.
    N Engl J Med. 2022 Jul 20. doi: 10.1056/NEJMc2203985.
    

    >> Share

    
    
35. TAN SHX, Cook AR, Heng D, Ong B, et al
    Effectiveness of BNT162b2 Vaccine against Omicron in Children 5 to 11 Years of Age.
    N Engl J Med. 2022 Jul 20. doi: 10.1056/NEJMoa2203209.
    

    >> Share

    
    
36. KOHANE I, Omenn GS
    Understanding Covid Vaccine Efficacy over Time - Bridging a Gap Between Public Health and Health Care.
    N Engl J Med. 2022 Aug 6. doi: 10.1056/NEJMp2201084.
    

    >> Share

    
    
37. JOST TS
    Considering Race and Ethnicity in Covid Risk Assessments - Legal Concerns and Possible Solutions.
    N Engl J Med. 2022;387:481-483.
    

    >> Share

    
    
38. RUBIN EJ, Baden LR, Currier JS, Morrissey S, et al
    Audio Interview: Reinventing the Research Infrastructure to Address Covid-19.
    N Engl J Med. 2022;387:e13.
    

    >> Share

    
    
39. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Combating Covid-19 Today and Tomorrow.
    N Engl J Med. 2022;387:e17.
    

    >> Share

    
    

    
    PLoS Biol

40. ROELLE SM, Shukla N, Pham AT, Bruchez AM, et al
    Expanded ACE2 dependencies of diverse SARS-like coronavirus receptor binding domains.
    PLoS Biol. 2022;20:e3001738.
    

    >> Share

    
    
41. LIU H, Riggi M, Rogers J, Meyer M, et al
    A new tool for annotating scientific animations and supporting scientific dialogue.
    PLoS Biol. 2022;20:e3001731.
    

    >> Share

    
    

    
    PLoS Med

42. SAARINEN S, Moustgaard H, Remes H, Sallinen R, et al
    Income differences in COVID-19 incidence and severity in Finland among people with foreign and native background: A population-based cohort study of individuals nested within households.
    PLoS Med. 2022;19:e1004038.
    

    >> Share

    
    

    
    PLoS One

43. DE REUS YA, Hagedoorn P, Sturkenboom MGG, Grasmeijer F, et al
    Tolerability and pharmacokinetic evaluation of inhaled dry powder hydroxychloroquine in healthy volunteers.
    PLoS One. 2022;17:e0272034.
    

    >> Share

    
    
44. RIEDEL M, Amann N, Recker F, Hennigs A, et al
    The COVID-19 pandemic and its impact on medical teaching in obstetrics and gynecology-A nationwide expert survey among teaching coordinators at German university hospitals.
    PLoS One. 2022;17:e0269562.
    

    >> Share

    
    
45. THORPE A, Fagerlin A, Butler J, Stevens V, et al
    Communicating about COVID-19 vaccine development and safety.
    PLoS One. 2022;17:e0272426.
    

    >> Share

    
    
46. SUN F, Qian P, Cao S, Chen Y, et al
    The impact of crop specialization on nutritional intake: Evidence from farm households in China.
    PLoS One. 2022;17:e0272347.
    

    >> Share

    
    
47. MATALONI F, Colais P, Pinnarelli L, Fusco D, et al
    The impact of the SARS COV-2 pandemic on pediatric accesses in ED: A Healthcare Emergency Information System analysis.
    PLoS One. 2022;17:e0272569.
    

    >> Share

    
    
48. AEMRO A, Fentie B, Wassie M
    Adherence to Covid-19 mitigation measures and its associated factors among health care workers at referral hospitals in Amhara regional state of Ethiopia.
    PLoS One. 2022;17:e0272570.
    

    >> Share

    
    
49. ARNETZ BB, Goetz C, vanSchagen J, Baer W, et al
    Patient-reported factors associated with avoidance of in-person care during the COVID-19 pandemic: Results from a national survey.
    PLoS One. 2022;17:e0272609.
    

    >> Share

    
    
50. AL-OBAYDI S, Hennrikus E, Mohammad N, Lehman EB, et al
    Hesitancy and reactogenicity to mRNA-based COVID-19 vaccines-Early experience with vaccine rollout in a multi-site healthcare system.
    PLoS One. 2022;17:e0272691.
    

    >> Share

    
    
51. WILLIAMS CP, Rocque GB, Caston NE, Gallagher KD, et al
    Health insurance and financial hardship in cancer survivors during the COVID-19 pandemic.
    PLoS One. 2022;17:e0272740.
    

    >> Share

    
    
52. NGUYEN N, Lane B, Lee S, Gorman SL, et al
    A mixed methods study evaluating acceptability of a daily COVID-19 testing regimen with a mobile-app connected, at-home, rapid antigen test: Implications for current and future pandemics.
    PLoS One. 2022;17:e0267766.
    

    >> Share

    
    
53. AGGARWAL S, Jeong D, Kumar N, Park DS, et al
    COVID-19 market disruptions and food security: Evidence from households in rural Liberia and Malawi.
    PLoS One. 2022;17:e0271488.
    

    >> Share

    
    
54. OKENDO J, Musanabaganwa C, Mwangi P, Nyaga M, et al
    SARS-CoV-2-positive patients display considerable differences in proteome diversity in urine, nasopharyngeal, gargle solution and bronchoalveolar lavage fluid samples.
    PLoS One. 2022;17:e0271870.
    

    >> Share

    
    
55. PONNAIAH M, Ganesan S, Bhatnagar T, Thulasingam M, et al
    Hyperglycemia and steroid use increase the risk of rhino-orbito-cerebral mucormycosis regardless of COVID-19 hospitalization: Case-control study, India.
    PLoS One. 2022;17:e0272042.
    

    >> Share

    
    
56. CASTELLANOS-SERRANO C, Escribano G, Paredes-Gazquez J, San-Martin Gonzalez E, et al
    What is behind the gender gap in economics distance education: Age, work-life balance and COVID-19.
    PLoS One. 2022;17:e0272341.
    

    >> Share

    
    
57. MCDERMID P, Sooppiyaragath S, Craig A, Sheel M, et al
    Psychological and financial impacts of COVID-19-related travel measures: An international cross-sectional study.
    PLoS One. 2022;17:e0271894.
    

    >> Share

    
    
58. TAHA M, Elahi M, Wahby K, Samavati L, et al
    Incidence and risk factors of COVID-19 associated pneumothorax.
    PLoS One. 2022;17:e0271964.
    

    >> Share

    
    
59. ALAHYARI S, Rajaeinejad M, Jalaeikhoo H, Chegini L, et al
    Immunological evaluation of patients with 2019 novel coronavirus pneumonia: CD4+ and CD16+ cells may predict severity and prognosis.
    PLoS One. 2022;17:e0268712.
    

    >> Share

    
    
60. KUNNO J, Supawattanabodee B, Sumanasrethakul C, Wiriyasirivaj B, et al
    Burnout prevalence and contributing factors among healthcare workers during the COVID-19 pandemic: A cross-sectional survey study in an urban community in Thailand.
    PLoS One. 2022;17:e0269421.
    

    >> Share

    
    
61. KOLTE A, Mahajan Y, Vasa L
    Balanced diet and daily calorie consumption: Consumer attitude during the COVID-19 pandemic from an emerging economy.
    PLoS One. 2022;17:e0270843.
    

    >> Share

    
    
62. CALVO-PANIAGUA J, Diaz-Arribas MJ, Valera-Calero JA, Gallardo-Vidal MI, et al
    A tele-health primary care rehabilitation program improves self-perceived exertion in COVID-19 survivors experiencing Post-COVID fatigue and dyspnea: A quasi-experimental study.
    PLoS One. 2022;17:e0271802.
    

    >> Share

    
    
63. RICHARDSON S, Martinez J, Hirsch JS, Cerise J, et al
    Association of race/ethnicity with mortality in patients hospitalized with COVID-19.
    PLoS One. 2022;17:e0267505.
    

    >> Share

    
    
64. FACCIN M, Gargiulo F, Atlani-Duault L, Ward JK, et al
    Assessing the influence of French vaccine critics during the two first years of the COVID-19 pandemic.
    PLoS One. 2022;17:e0271157.
    

    >> Share

    
    
65. SANGVERAPHUNSIRI T, Fukushige T, Jongwiriyanurak N, Tanaksaranond G, et al
    Impacts of the COVID-19 pandemic on the spatio-temporal characteristics of a bicycle-sharing system: A case study of Pun Pun, Bangkok, Thailand.
    PLoS One. 2022;17:e0272537.
    

    >> Share

    
    
66. HAMMAMI R, Jdidi J, Chakroun O, Issaoui F, et al
    Thromboembolic events in COVID-19 ambulatory patients: An observational study about incidence, and thromboprophylaxis outcomes.
    PLoS One. 2022;17:e0270195.
    

    >> Share

    
    
67. MARAHWA P, Makota P, Chikomo DT, Chakanyuka T, et al
    The psychological impact of COVID-19 on university students in China and Africa.
    PLoS One. 2022;17:e0270824.
    

    >> Share

    
    
68. AUDEMARD-VERGER A, Le Gouge A, Pestre V, Courjon J, et al
    Efficacy and safety of anakinra in adults presenting deteriorating respiratory symptoms from COVID-19: A randomized controlled trial.
    PLoS One. 2022;17:e0269065.
    

    >> Share

    
    
69. DENETCLAW WF, Otto ZK, Christie S, Allen E, et al
    Dine Navajo Resilience to the COVID-19 pandemic.
    PLoS One. 2022;17:e0272089.
    

    >> Share

    
    
70. AKTER Y, Barua R, Nasir Uddin M, Muhammad Sanaullah AF, et al
    Bioactive potentiality of secondary metabolites from endophytic bacteria against SARS-COV-2: An in-silico approach.
    PLoS One. 2022;17:e0269962.
    

    >> Share

    
    
71. SILVERBERG JI, Zyskind I, Naiditch H, Zimmerman J, et al
    Predictors of chronic COVID-19 symptoms in a community-based cohort of adults.
    PLoS One. 2022;17:e0271310.
    

    >> Share

    
    
72. RAO S, Moss A, Lamb M, Innis BL, et al
    Vital sign predictors of severe influenza among children in an emergent care setting.
    PLoS One. 2022;17:e0272029.
    

    >> Share

    
    
73. HUIBERTS A, van Cleef B, Tjon-A-Tsien A, Dijkstra F, et al
    Influenza vaccination of school teachers: A scoping review and an impact estimation.
    PLoS One. 2022;17:e0272332.
    

    >> Share

    
    
74. JAMLEH A, Aljohani SM, Alzamil FF, Aljuhayyim SM, et al
    Assessment of the educational value of endodontic access cavity preparation YouTube video as a learning resource for students.
    PLoS One. 2022;17:e0272765.
    

    >> Share

    
    
75. RAYAMAJHI S, Rafi MA, Tripathi N, Dongol AS, et al
    Adverse events following immunization with ChAdOx1 nCoV-19 and BBIBP-CorV vaccine: A comparative study among healthcare professionals of Nepal.
    PLoS One. 2022;17:e0272729.
    

    >> Share

    
    
76. FU Y, da Fonseca Rezende E Mello J, Fleming BD, Renn A, et al
    A humanized nanobody phage display library yields potent binders of SARS CoV-2 spike.
    PLoS One. 2022;17:e0272364.
    

    >> Share

    
    
77. ATHAYDE GM, Alencar AP
    Forecasting Covid-19 in the United Kingdom: A dynamic SIRD model.
    PLoS One. 2022;17:e0271577.
    

    >> Share

    
    
78. BRANDSMA J, Chenoweth JG, Gregory MK, Krishnan S, et al
    Assessing the use of a micro-sampling device for measuring blood protein levels in healthy subjects and COVID-19 patients.
    PLoS One. 2022;17:e0272572.
    

    >> Share

    
    
79. SHAH S, Bhattarai SR, Basnet K, Adhikari YR, et al
    Post-COVID syndrome: A prospective study in a tertiary hospital of Nepal.
    PLoS One. 2022;17:e0272636.
    

    >> Share

    
    
80. GEHANNO JF, Grosjean J, Darmoni SJ, Rollin L, et al
    Reliability of citations of medRxiv preprints in articles published on COVID-19 in the world leading medical journals.
    PLoS One. 2022;17:e0264661.
    

    >> Share

    
    
81. SARJOMAA M, Diep LM, Zhang C, Tveten Y, et al
    SARS-CoV-2 antibody persistence after five and twelve months: A cohort study from South-Eastern Norway.
    PLoS One. 2022;17:e0264667.
    

    >> Share

    
    
82. ALSAGABY SA, Alharbi NK, Alhumaydhi FA, Alsubaie F, et al
    Risk factors of SARS-CoV-2 infection in cancer patients pre- and post-vaccination.
    PLoS One. 2022;17:e0272869.
    

    >> Share

    
    
83. NKA AD, Ka'e AC, Bouba Y, Ngoufack Jagni Semengue E, et al
    Global burden of SARS-CoV-2 infection, hospitalization and case fatality rate among COVID-19 vaccinated individuals and its associated factors: A systematic review and meta-analysis protocol.
    PLoS One. 2022;17:e0272839.
    

    >> Share

    
    
84. CHENG HY, Fung E, Choi KC, Zou HJ, et al
    Early risk of acute myocardial infarction following hospitalization for severe influenza infection in the middle-aged population of Hong Kong.
    PLoS One. 2022;17:e0272661.
    

    >> Share

    
    
85. MARSDEN KM, Robertson IK, Porter J
    Stressors, manifestations and course of COVID-19 related distress among public sector nurses and midwives during the COVID-19 pandemic first year in Tasmania, Australia.
    PLoS One. 2022;17:e0271824.
    

    >> Share

    
    
86. GEBEYEHU DT, East L, Wark S, Islam MS, et al
    Impact of COVID-19 on the food security and identifying the compromised food security dimension: A systematic review protocol.
    PLoS One. 2022;17:e0272859.
    

    >> Share

    
    
87. DIETEREN CM, van Hulsen MAJ, Rohde KIM, van Exel J, et al
    How should ICU beds be allocated during a crisis? Evidence from the COVID-19 pandemic.
    PLoS One. 2022;17:e0270996.
    

    >> Share

    
    
88. NGUYEN LH, Anyane-Yeboa A, Klaser K, Merino J, et al
    The mental health burden of racial and ethnic minorities during the COVID-19 pandemic.
    PLoS One. 2022;17:e0271661.
    

    >> Share

    
    
89. MEGHANI A, Agarwal S, Zapf AJ, Edwards JG, et al
    Schooling amidst a pandemic in the United States: Parents' perceptions about reopening schools and anticipated challenges during COVID-19.
    PLoS One. 2022;17:e0268427.
    

    >> Share

    
    
90. MARK E, Udod G, Skinner J, Jones M, et al
    Knowledge, attitudes, and practices [KAP] toward COVID-19: A cross-sectional study in the New York Metropolitan Area and California Bay Area.
    PLoS One. 2022;17:e0271212.
    

    >> Share

    
    
91. PARK HJ, Lee SG, Oh JS, Nam M, et al
    The effects of indoor temperature and humidity on local transmission of COVID-19 and how it relates to global trends.
    PLoS One. 2022;17:e0271760.
    

    >> Share

    
    
92. HAGHANI M, Abbasi A, Zwack CC, Shahhoseini Z, et al
    Trends of research productivity across author gender and research fields: A multidisciplinary and multi-country observational study.
    PLoS One. 2022;17:e0271998.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

93. LI W, Wang Q, Liu Y, Small ML, et al
    A spatiotemporal decay model of human mobility when facing large-scale crises.
    Proc Natl Acad Sci U S A. 2022;119:e2203042119.
    

    >> Share

    
    
94. NOONE DP, Dijkstra DJ, van der Klugt TT, van Veelen PA, et al
    PTX3 structure determination using a hybrid cryoelectron microscopy and AlphaFold approach offers insights into ligand binding and complement activation.
    Proc Natl Acad Sci U S A. 2022;119:e2208144119.
    

    >> Share

    
    
95. GARCIA-MORO E, Zhang J, Calder LJ, Brown NR, et al
    Reversible structural changes in the influenza hemagglutinin precursor at membrane fusion pH.
    Proc Natl Acad Sci U S A. 2022;119:e2208011119.
    

    >> Share

    
    
96. YANG Z, Wu D, Lu S, Qiu Y, et al
    Plasma metabolome and cytokine profile reveal glycylproline modulating antibody fading in convalescent COVID-19 patients.
    Proc Natl Acad Sci U S A. 2022;119:e2117089119.
    

    >> Share

    
    
97. JOSEPH M, Wu Y, Dannebaum R, Rubelt F, et al
    Global patterns of antigen receptor repertoire disruption across adaptive immune compartments in COVID-19.
    Proc Natl Acad Sci U S A. 2022;119:e2201541119.
    

    >> Share

    
    
98. CARIOU M, Picard L, Gueguen L, Jacquet S, et al
    Distinct evolutionary trajectories of SARS-CoV-2-interacting proteins in bats and primates identify important host determinants of COVID-19.
    Proc Natl Acad Sci U S A. 2022;119:e2206610119.
    

    >> Share

    
    

    
    Vaccine

99. CHEN H, Huang Z, Chang S, Hu M, et al
    Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (Sinopharm BBIBP-CorV) coadministered with quadrivalent split-virion inactivated influenza vaccine and 23-valent pneumococcal polysaccharide vaccine in China: A multicentre, non-inferiorit
    Vaccine. 2022 Jul 29. pii: S0264-410X(22)00919.
    

    >> Share

    
    
100. SHENYU W, Xiaoqian D, Bo C, Xuan D, et al
     Immunogenicity and safety of a SARS-CoV-2 inactivated vaccine (CoronaVac) co-administered with an inactivated quadrivalent influenza vaccine: A randomized, open-label, controlled study in healthy adults aged 18 to 59 years in China.
     Vaccine. 2022 Jul 26. pii: S0264-410X(22)00908.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share